NCT03535428

Venous Thrombo-embolic Complication prévention in Pelvic Surgery

Completed Last updated 3 October 2019

What this trial tests

trial testing VENOUS exploration in Venous Thromboembolism in 100 participants. Completed in 31 August 2019.

Timeline

13 February 2017

Primary endpoint
25 April 2018

31 August 2019

Quick facts

Lead sponsor	Fondation Hôpital Saint-Joseph
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	13 February 2017
Primary completion	25 April 2018
Estimated completion	31 August 2019
Sites	1 location across France

Drugs / interventions tested

• VENOUS exploration

Conditions studied

• Venous Thromboembolism — all drugs for Venous Thromboembolism →
• Pelvic Surgery — all drugs for Pelvic Surgery →

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Venous Thromboembolism or Pelvic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pelvic fracture surgery are very high thrombotic risk surgery with about 10% to 50% venous thrombo embolic complications and 0.5% to 10% of pulmonary embolism. The ST JOSEPH's Hospital have almost 60 cases per year . Following a fatal pulmonary embolism per operatory the team has set up a venous exploratory protocol before surgery.

This protocol includes a venous doppler ultrasound of lower limbs associated to a abdo pelvic scanner in the 48hours before surgery.

The aim is to evaluate this new protocol efficacy on prevention of thrombo embolic complications in pelvic fracture surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Abstracts
   · 2020